Telemedicine Technologies has developed a technological innovation platformcalled “CleanWEB-MAP” (CleanWEB Managed Access Programmes) that facilitates access to new drugs to eligible patients, as long as specific criteria and requirements are met. There are multiple terms that fall under the umbrella of MAP, including Compassionate Use, Early Access, Named Patient Use or even Individual Patient Request Programmes amongst others. The terms used may vary from country to country depending on local laws and regulations.
Our module is tightly linked to our CleanWEB software platform of medical data collection, it allows self-registration of prescribing physicians and pharmacists, for each new product related to MAP.
This webinar will be led by Yoani Matsakis, CEO of Telemedicine Technologies who will be available to answer your questions at the end of the session.
Telemedicine Technologies is one of the leaders in Europe of studies management solutions for academic research and health industries. Major pharmaceutical groups have already entrusted us with the implementation of their MAP.
Come and join our webinar to learn more about Managed Access Programmes: